Company / Operating Cash Flow per Share
Boston Scientific Operating Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
$3.03
FY2025
5-year range
$1.06 / $3.03
FY2021-FY2025
Trend
+31.2%
vs FY2024
Sector context
#73 of 161
Health Care
What the data says
At $3.03, Boston Scientific's operating cash flow per share ranks #73 of 161 in the Health Care sector. Operating Cash Flow per Share has increased for 3 consecutive years, from $1.06 in FY2022 to $3.03 in FY2025.
Based on SEC 10-K filings.
3.03 in FY2025 with a 5-year CAGR of +68.8%.
Improved from $1.75 to $3.03 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- +42.0%
- 5-Year CAGR
- +68.8%
- 10-Year CAGR
- -
Sector benchmark
#73 of 161 in Health CareTop 45% of 161This company $3.03 Sector average $6.67
▼
-54.5% below sector average
Key checks
Key Insights
- Boston Scientific's operating cash flow per share has grown for 3 consecutive years.
- In FY2025, operating cash flow per share increased 31.2% year-over-year.
- Ranks #73 out of 161 companies in the Health Care sector.
- Lowest operating cash flow per share in the period was in FY2020.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.03 | +31.2% |
| FY2024 | $2.31 | +32.4% |
| FY2023 | $1.75 | +64.7% |
| FY2022 | $1.06 | -18.6% |
| FY2021 | $1.30 | +488.4% |
| FY2020 | $0.22 | -83.2% |
| FY2019 | $1.32 | +487.9% |
| FY2018 | $0.22 | -78.4% |
| FY2017 | $1.04 | +18.3% |
| FY2016 | $0.88 | +68.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026